DOJ Investigation Concerns: Recent chatter on X about UnitedHealth Group (UNH) has been dominated by the ongoing Department of Justice investigation into Medicare billing practices. Many express deep worry over potential financial penalties that could worsen the stock’s significant year-to-date decline. The regulatory scrutiny continues to fuel unease among investors.
Analyst Upgrades and Recovery Hopes: Despite the regulatory headwinds, some discussions on X highlight a glimmer of optimism with recent analyst upgrades, including a raised price target to $375 by a major research firm. There’s talk of potential margin recovery and long-term earnings growth, sparking cautious hope. This has led to a slight uptick in positive sentiment for the stock.
Note: This discussion summary was generated from an AI condensation of post data.
UnitedHealth Group Insider Trading Activity
UnitedHealth Group insiders have traded $UNH stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $UNH stock by insiders over the last 6 months:
- PATRICK HUGH CONWAY (Chief Executive Officer, Optum) sold 589 shares for an estimated $179,645
- CHARLES D. BAKER sold 27 shares for an estimated $9,613
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
UnitedHealth Group Revenue
UnitedHealth Group had revenues of $113.2B in Q3 2025. This is an increase of 12.24% from the same period in the prior year.
You can track UNH financials on Quiver Quantitative's UNH stock page.
UnitedHealth Group Congressional Stock Trading
Members of Congress have traded $UNH stock 27 times in the past 6 months. Of those trades, 12 have been purchases and 15 have been sales.
Here’s a breakdown of recent trading of $UNH stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN has traded it 6 times. They made 3 purchases worth up to $45,000 on 10/30, 08/13, 06/17 and 3 sales worth up to $45,000 on 10/31, 10/30, 06/24.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 3 times. They made 2 purchases worth up to $30,000 on 10/09, 09/05 and 1 sale worth up to $50,000 on 08/05.
- SENATOR MARKWAYNE MULLIN has traded it 2 times. They made 1 purchase worth up to $50,000 on 09/24 and 1 sale worth up to $50,000 on 08/01.
- REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.
- REPRESENTATIVE RICHARD MCCORMICK sold up to $15,000 on 09/18.
- SENATOR SHELDON WHITEHOUSE has traded it 2 times. They made 0 purchases and 2 sales worth up to $100,000 on 09/04, 08/28.
- REPRESENTATIVE MARJORIE TAYLOR GREENE has traded it 2 times. They made 2 purchases worth up to $30,000 on 08/28, 08/04 and 0 sales.
- REPRESENTATIVE TIM MOORE has traded it 5 times. They made 4 purchases worth up to $130,000 on 08/08, 08/01, 07/21, 07/16 and 1 sale worth up to $100,000 on 08/15.
- REPRESENTATIVE JULIE JOHNSON has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 08/14, 07/24.
- SENATOR ANGUS S. KING JR. sold up to $15,000 on 07/15.
- SENATOR SHELLEY MOORE CAPITO sold up to $15,000 on 06/23.
- SENATOR JOHN BOOZMAN sold up to $15,000 on 06/11.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
UnitedHealth Group Hedge Fund Activity
We have seen 1,597 institutional investors add shares of UnitedHealth Group stock to their portfolio, and 2,130 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WELLINGTON MANAGEMENT GROUP LLP removed 7,697,387 shares (-31.8%) from their portfolio in Q3 2025, for an estimated $2,657,907,731
- CAPITAL RESEARCH GLOBAL INVESTORS added 7,293,009 shares (+126.9%) to their portfolio in Q3 2025, for an estimated $2,518,276,007
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 5,146,915 shares (+59.8%) to their portfolio in Q3 2025, for an estimated $1,777,229,749
- PRICE T ROWE ASSOCIATES INC /MD/ removed 3,768,686 shares (-17.2%) from their portfolio in Q3 2025, for an estimated $1,301,327,275
- CAPITAL WORLD INVESTORS added 3,439,182 shares (+18.8%) to their portfolio in Q3 2025, for an estimated $1,187,549,544
- FMR LLC removed 3,112,368 shares (-18.5%) from their portfolio in Q3 2025, for an estimated $1,074,700,670
- APPALOOSA LP removed 2,246,500 shares (-91.7%) from their portfolio in Q3 2025, for an estimated $775,716,450
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
UnitedHealth Group Government Contracts
We have seen $16,214,442,209 of award payments to $UNH over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- EXPRESS REPORT: R3 FY25 3RD QTR APRIL: $830,362,703
- EXPRESS REPORT: R3 FY25 3RD QTR MAY: $819,320,444
- EXPRESS REPORT: R3 FY25 2ND QTR MARCH: $791,841,212
- EXPRESS REPORT: R3 FY25 1ST QTR OCTOBER: $771,731,035
- EXPRESS REPORT: R3 FY25 1ST QTR NOVEMBER: $749,361,473
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
UnitedHealth Group Analyst Ratings
Wall Street analysts have issued reports on $UNH in the last several months. We have seen 14 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Bernstein issued a "Outperform" rating on 10/30/2025
- RBC Capital issued a "Outperform" rating on 10/29/2025
- Piper Sandler issued a "Overweight" rating on 10/29/2025
- UBS issued a "Buy" rating on 10/29/2025
- Jefferies issued a "Buy" rating on 10/17/2025
- Goldman Sachs issued a "Buy" rating on 10/14/2025
- Keybanc issued a "Overweight" rating on 10/08/2025
To track analyst ratings and price targets for UnitedHealth Group, check out Quiver Quantitative's $UNH forecast page.
UnitedHealth Group Price Targets
Multiple analysts have issued price targets for $UNH recently. We have seen 18 analysts offer price targets for $UNH in the last 6 months, with a median target of $403.0.
Here are some recent targets:
- Ryan Langston from TD Cowen set a target price of $338.0 on 10/30/2025
- Lance Wilkes from Bernstein set a target price of $440.0 on 10/30/2025
- Jessica Tassan from Piper Sandler set a target price of $417.0 on 10/29/2025
- Kevin Caliendo from UBS set a target price of $430.0 on 10/29/2025
- Ben Hendrix from RBC Capital set a target price of $408.0 on 10/29/2025
- David Windley from Jefferies set a target price of $409.0 on 10/17/2025
- Scott Fidel from Goldman Sachs set a target price of $406.0 on 10/14/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
